Skip to content

Study of Jasakadi Rasayan in the management of early changes of diabetic retinopathy with the help of OCT(optical coherence tomography) machine.

Clinical Study of Jasakadi Rasayan in the management of non-proliferative diabetic retinopathy with Optical Coherence Tomography (OCT) biomarkers as visual outcome predictors - NIL

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/07/091256
Enrollment
80
Registered
2025-07-21
Start date
Unknown
Completion date
Unknown
Last updated
2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H350- Background retinopathy and retinalvascular changes

Interventions

None listed

Sponsors

Aparna Prakash Bhoite
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients with type 2 Diabetes with or without visual disturbances, but with detectable ophthalmoscopic features of mild to moderate Non-proliferative Diabetic Retinopathy (such as exudates, hemorrhage, microaneurysm, cotton wool spots)

Exclusion criteria

Exclusion criteria: 1 The patients with type 1 Diabetes or type 2 Diabetes taking insulin 2 Patients with recent cataract surgery within the previous 3 months 3 Hazy media for fundus evaluation 4 History of proliferative diabetic retinopathy (PDR) or other advanced eye diseases (retinal detachment, uveitis, Glaucoma, etc.). 5 Active uncontrolled systemic diseases 6 Pregnant or breastfeeding women 7 Participants in another clinical trial within the past 3 months

Design outcomes

Primary

MeasureTime frame
Improvement in key OCT Biomarkers OR BCVA(best corrected visual acuity) improvement of minimum 5 letters or more on the vision chart after treatmentTimepoint: Duration of treatment- 3 months Follow up at the end of 1 month and 3 month

Secondary

MeasureTime frame
To assess the effect of Jasakadi Rasayan on HbA1C levels with adjuvant conventional antidiabetic treatmentTimepoint: Duration of treatment- 3 months Follow up at the end of 1 month and 3 month

Countries

India

Contacts

Public ContactDr Aparna Prakash Bhoite

PDEAs College of Ayurved and Research Centre, Nigadi, Pune

drvirkarchandana@gmail.com9822199107

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026